Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
Login | Create an Account

SCSHP Annual Meeting 2018 (Pharmacists)


The South Carolina Society of Health-System Pharmacists 2018 Annual Meeting
will be held Sunday, March 11th through Tuesday, March 13th
at the Marriott Hilton Head Resort & Spa in Hilton Head, South Carolina!
 
Please visit http://www.scshp.com/events/EventDetails.aspx?id=851272&group= for all registration details, including pricing.
 
The schedule of learning activities, session titles, speakers, learning objectives, ACPE UANs, and credit hours can be viewed through expanding the sessions below!

Date: Mar 11, 2018 08:00 AM - Mar 13, 2018 11:30 AM

CE Hours

15.00

CE Units

1.500

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

SCSHP

Requirements for CE Credit

In order to claim credit and have CE credit submitted to the CPE Monitor, participants must complete the following steps within 60 days of the event.  Completion of these steps within 30 days of the event will allow for any issues in transmission to NABP to be rectified by our office. The CPE Monitor will not accept credit that is submitted greater than 60 days after the event.
  1. Check in upon arrival at the meeting
  2. Complete and submit their "CE Sign In" form at the meeting
  3. Complete the online program evaluation
  4. Update their accounts to properly reflect their month and day of birth and their correct NABP E-Id.  Registration with a proper disclosure of your NABP E-Id is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP E-Id, please click on the CPE Monitor logo below to be directed to their site.  

 

 

 

 

At the completion of this activity, the pharmacist will be able to:
  1. Identify the incidence of clinician stress and burnout
  2. Describe approaches to promote a resilient work environment
  3. Discuss the importance of developing pharmacists as clinician leaders
  4. Describe the current and emerging roles of pharmacy technicians
  5. Evaluate new requirements for accredited technician education
  6. Discuss solutions to the pharmacy technician workforce shortage

Speaker(s)/Author(s)

Paul W. Bush, PharmD, MBA, BCPS, FASHP
Vice President for Global Resource Development and Consulting, American Society of Health-System Pharmacists (ASHP)

Activity Number

0062-9999-18-071-L04-P
Date: 03/11/18
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recognize opioid prescribing which is outside of normal prescribing patterns
  2. Detect various red flags for inappropriate prescribing of controlled substances 

Speaker(s)/Author(s)

Debra Black
DEA Diversion Group Supervisor, Drug Enforcement Administration

Activity Number

0062-9999-18-072-L03-P
Date: 03/11/18
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Evaluate ACCE/ACE 2016 osteoporosis guidelines
  2. Recall osteoporosis medications and their role in management
  3. Utilize clinical pearls in the management of osteoporosis
  4. Discuss new evidence and studies related to osteoporosis

Activity Number

0062-9999-18-073-L01-P
Date: 03/11/18
Time: 11:45 AM - 12:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Apply clinical knowledge to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Demonstrate competency across numerous drug therapy and specialty areas through application of knowledge to pharmacotherapy questions

Activity Number

0062-9999-18-074-L04-P
Date: 03/11/18
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Discuss emerging research outcomes from throughout the state of South Carolina
  2. Apply novel ideas for research and quality initiative projects in your pharmacy practice areas
  3. Acknowledge pivotal results from local investigations across the state of South Carolina

Activity Number

0062-9999-18-075-L04-P
Date: 03/11/18
Time: 03:15 PM - 04:45 PM

CE Hours

1.50
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Apply clinical knowledge to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Demonstrate competency across numerous drug therapy and specialty areas through application of knowledge to pharmacotherapy questions

Activity Number

0062-9999-18-076-L04-P
Date: 03/11/18
Time: 04:45 PM - 05:15 PM

CE Hours

0.50
 

 

 

At the completion of this activity, the pharmacist will be able to:
  1. Review highlights of USP <797> and <800> as currently published
  2. Discuss current compliance trends in sterile compounding in accordance with USP <797>
  3. Describe the most significant upcoming changes to USP <797>
  4. Explain the impact of USP updates on current sterile compounding practices

Speaker(s)/Author(s)

Michaela Almgren, PharmD, MS
Clinical Assistant Professor, University of South Carolina College of Pharmacy

Activity Number

0062-9999-18-081-L07-P
Date: 03/12/18
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Identify the short term and long term effects of opioid abuse in pregnancy
  2. Interpret data in relation to the opioid epidemic in South Carolina and nationwide
  3. Recommend potential treatment options for an opioid-dependent pregnant female to optimize maternal outcomes
  4. Develop a regimen for the treatment of neonatal abstinence syndrome

Speaker(s)/Author(s)

Katie Ellis, PharmD
Assistant Professor, Presbyterian College School of Pharmacy

Activity Number

0062-9999-18-082-L01-P
Date: 03/12/18
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe a five-domain model for organizing and implementing practices for development of resilience and prevention of burnout
  2. Apply mindfulness practice to the work setting
  3. Develop a personalized set of practices to build emotional intelligence and resilience

Speaker(s)/Author(s)

Michael Wiederman, PhD
Director of Professional Development, USC School of Medicine Greenville

Activity Number

0062-9999-18-083-L04-P
Date: 03/12/18
Time: 11:45 AM - 12:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Discuss benefits of appropriate empirical antimicrobial therapy in patients with serious infections
  2. Review risks of non-stratified use of broad-spectrum antimicrobial agents
  3. Demonstrate role of prior antimicrobial use among other patient-specific risk factors for antimicrobial resistance
  4. Utilize clinical tools for prediction of antimicrobial resistance in decision-making of empirical therapy

Speaker(s)/Author(s)

Majdi Al-Hasan, MBBS
Professor of Medicine, Department of Medicine, Division of Infectious Diseases, University of South Carolina School of Medicine; Director, Antimicrobial Stewardship and Support Team, Prisma Health-Midlands

Activity Number

0062-9999-18-084-L01-P
Date: 03/12/18
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Explain how critical illness alters drug absorption and distribution
  2. Describe the effects of changing hepatic blood flow and protein binding on drug metabolism
  3. Differentiate methods of approximating renal clearance
  4. Identify methods to optimize the pharmacodynamic activity of antibiotics in critically ill patients

Speaker(s)/Author(s)

Jason Haney
Assistant Professor, South Carolina College of Pharmacy - MUSC Campus

Activity Number

0062-9999-18-085-L01-P
Date: 03/12/18
Time: 03:00 PM - 04:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe the role of neratinib in the extended adjuvant treatment of HER2-positive breast cancer and recommend appropriate supportive care with its use
  2. Examine the role of CDK4/6 inhibitors in the treatment of hormone receptor-positive metastatic breast cancer
  3. Analyze the clinical benefit of durvalumab consolidation following chemoradiation in non-small cell lung cancer
  4. Evaluate the role of alectinib and brigatinib for the treatment of ALK-positive non-small cell lung cancer

Speaker(s)/Author(s)

Donald Moore, PharmD, BCPS, BCOP, DPLA
Oncology Pharmacist Clinical Coordinator, Levine Cancer Institute

Activity Number

0062-9999-18-086-L01-P
Date: 03/12/18
Time: 04:15 PM - 05:15 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe how the delivery of healthcare from a fee-for-service model to value-based care impacts ambulatory care pharmacy practice
  2. Explore successful models for integrating pharmacists into patient-centered, team-based primary care practices
  3. Discuss primary care practice characteristics that indicate "practice readiness" for collaborative pharmacy practice

Speaker(s)/Author(s)

Mollie Ashe Scott, PharmD, BCACP, CPP, FASHP
Regional Associate Dean & Clinical Associate Professor, UNC Eshelman School of Pharmacy, Asheville

Activity Number

0062-9999-18-090-L04-P
Date: 03/13/18
Time: 08:30 AM - 09:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Review properties and key clinical trials for oral anticoagulants
  2. Discuss complexities and optimal management of patients with atrial fibrillation and concomitant coronary artery disease
  3. Analyze and recommend oral anticoagulant options for special populations
  4. Apply literature and guideline recommendations to develop therapeutic plans for patient cases

Speaker(s)/Author(s)

Janna Beavers, MS, PharmD, BCPS
Cardiology Clinical Pharmacy Specialist, WakeMed Health & Hospitals

Activity Number

0062-9999-18-091-L01-P
Date: 03/13/18
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe the mechanism of action of select new drugs approved by the FDA in 2017
  2. Summarize the data submitted for approval and place in therapy for selected drugs
  3. Identify clinically significant adverse effects, drug interactions, appropriate dosing and monitoring of the new drugs presented

Speaker(s)/Author(s)

Lloyd Sarbacker, PharmD, BCPS
Clinical Pharmacy Supervisor, Bon Secours St. Francis Health System

Activity Number

0062-9999-18-092-L01-P
Date: 03/13/18
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 



 
University of South Carolina College of Pharmacy | 715 Sumter Street, Coker Life Sciences, Columbia, SC 29208 | 803-777-9979 | CE@cop.sc.edu
 
Powered By: Learning ExpressCE
Copyright © 2024 UofSC College of Pharmacy Continuing Education. All Rights Reserved.
About Us Privacy Policy Terms of Service